Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

NCT07108179 | Enrolling By Invitation

• 1 other identifier: SN-CGM-PO-002
• Study Type: observational
• Target: 120
• Locations: 1 country
• Sites: 1

Brief Summary

Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.

Conditions

Critically Ill Patients

Outcome Measures

Primary Outcomes (1)

• Accuracy

  "Comparison between arterial blood gas analysis glucose values and CGM values at the same time"

  Up to eight days

Interventions

Continuous Glucose Monitoring (CGM) System DEVICE

Continuous Glucose Monitoring (CGM) System

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Critically ill patients

You may qualify if:

• Age ≥ 18 years; gender not limited.
• Expected ICU (Intensive Care Unit) stay ≥ 48 hours.
• Patients requiring frequent blood gas monitoring in the ICU.

You may not qualify if:

• The patient or their family refuses to use CGM for blood glucose monitoring.
• Patients with adverse skin conditions (such as rash, active inflammation, etc.) in the device placement area, or those requiring emergency surgical intervention in that area.
• Patients who need to undergo computed tomography (CT), X-ray, or magnetic resonance imaging (MRI) scans on the device placement area during the study period.

Sponsors & Collaborators

• Sinocare: lead

Study Sites (1)

Continuous glucose monitoring system

Changsha, changsha, China

Location

MeSH Terms

Interventions

Continuous Glucose Monitoring; Drug Delivery Systems

Intervention Hierarchy (Ancestors)

Blood Chemical Analysis; Clinical Chemistry Tests; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Diagnostic Techniques, Endocrine; Monitoring, Physiologic; Investigative Techniques; Drug Therapy; Therapeutics

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 25, 2025
• First Posted: August 6, 2025
• Study Start: March 4, 2025
• Primary Completion: August 1, 2025
• Study Completion: September 1, 2025
• Last Updated: August 6, 2025

Record last verified: 2025-01

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)